Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D and Innate Responses: Recognition, Peptides and Function: Study Summary

Previous related pageVitamin D and Innate Responses: Recognition, Peptides and Function: Full Evidence ReviewNext related pageVitamin D and Innate Responses: Recognition, Peptides and Function: Full Evidence Review
Study at a glance

What was studied?

Researchers examined vitamin D and the body’s early immune responses. They studied human cells, tissues and small groups of people. They measured immune signals, small defence proteins and laboratory defence activity.

What did the studies find?

Some cell signals increased, while others decreased. The direction depended on the cell and the conditions studied. Raising vitamin D in people did not consistently increase the measured defence proteins or improve laboratory defence activity.

What does this mean?

A gene signal is different from the amount of working protein. A protein measurement is different from a test of defence activity. None of those measurements alone shows whether a person will have fewer infections.

What are the limits?

Several studies were small, had no comparison group or tested only some participants. Blood measurements did not always reflect what happened at a body surface. The selected studies do not establish a single vitamin D level that controls immune activation. They also do not provide a personal supplement dose or prove infection prevention.

Read the full article below ↓

Vitamin D can change selected early immune responses, but the effects are not uniformly stronger or weaker. Researchers have measured several different stages, from recognition signals to defence proteins and laboratory activity. Those stages need to be kept separate. For the full evidence and its limitations, read Vitamin D and Innate Responses: Recognition, Peptides and Function: Full Evidence Review.

Recognition signals do not define one immune threshold

Innate immunity includes the body’s rapid recognition and response systems. A cell can have more of a recognition receptor without producing the same change in every downstream response. The overview Vitamin D and Innate Immunity explains this early-response setting.

Liu and colleagues found that vitamin D-related signalling and another inflammatory signal worked together in selected human-monocyte responses. Different defence-peptide families had different requirements. Schauber and colleagues found injury-related recognition and peptide responses in skin, with important differences between human and mouse biology. Neither study demonstrated fewer infections in people.

Kundu and colleagues found opposing responses in different human immune-cell types: selected signals decreased in dendritic cells, were not attenuated in macrophages and increased in monocytes. Jeong and colleagues found reduced selected signals in stimulated skin cells. These findings do not support a universal claim that vitamin D always increases or suppresses innate responses.

Ojaimi and colleagues’ small uncontrolled study also found differences between receptor measurements and downstream messages. Important analyses selected responders, and participant numbers declined over follow-up. Kariuki and colleagues studied gene activity in cells from 20 donors. Selected defence-related signals increased while selected inflammatory programmes decreased, but gene activity did not demonstrate improved defence or clinical protection.

An activation threshold means the amount of stimulation needed for a defined response. These findings do not establish one blood vitamin D level that determines that threshold across the body. The broader issue of proportionate responses is explained in Vitamin D and Immune Overactivation.

More measured peptide does not necessarily mean better defence

Antimicrobial peptides are small proteins involved in defence and signalling. A gene message, a precursor protein and an active peptide are different measurements. Some tests recognise both precursor and processed forms. The overview Vitamin D and Antimicrobial Peptides introduces their biological role.

Hertting and colleagues examined bladder tissues and cells, alongside a very small uncontrolled human component. Their findings showed that local response and blood measurements did not simply change together. This review uses their expression findings, not the separate functional figure, and does not infer prevention of urinary infection.

Raqib and colleagues studied samples from a randomised prenatal vitamin D3 trial. Supplementation did not improve the measured neonatal cellular defence outcome. An apparent reduction in intracellular peptide depended on the statistical analysis, so it should not be treated as established suppression. It also did not demonstrate impaired defence. The report contains an inconsistency between allocation counts in the text and table.

Airway measurements illustrate the limits

Sanders and colleagues followed vitamin D-deficient current smokers. Seventeen of 29 enrolled participants completed the uncontrolled pilot. Blood vitamin D increased, but no rise in the measured cathelicidin was detected in blood or lung fluid. The small sample, losses and lack of placebo limit conclusions. The test did not isolate only the active peptide, and clinical infections were not measured.

Vargas Buonfiglio and colleagues examined airway-fluid defence activity in a randomised trial. The relevant functional analysis used only 40 samples from 98 randomised participants. A change within the supplemented group was not enough to establish an advantage over placebo. Exploratory smoking comparisons did not establish a different treatment effect in smokers. The study did not demonstrate clinical infection protection.

These airway studies measured different outcomes. They cannot be treated as identical tests of whether supplements improve defence. The wider context of Vitamin D and Mucosal Defence includes barriers, local signals and other functions that a single assay does not capture.

What does the evidence mean?

The selected studies show context-dependent immune responses and important gaps between molecular signals, peptide abundance and laboratory function. They do not establish a universal numerical activation threshold, a personal vitamin D target or infection prevention from supplements. A change in one stage should not be presented as proof of a benefit at every later stage.

This summary follows a selected comparative review, not a complete survey of every immune condition. Uninspected supplementary-only claims are excluded. Small samples, selected analyses, source discrepancies and shared research programmes remain limitations. The full review gives the detailed source-access record and distinguishes related publications from independent studies.

Sources

Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses. Liu PT et al.. PLoS ONE. 2009;4(6):e5810. DOI: 10.1371/journal.pone.0005810. PMID: 19503839.

Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary Bladder. Hertting O et al.. PLoS ONE. 2010;5(12):e15580. DOI: 10.1371/journal.pone.0015580. PMID: 21179490.

Related reading

Physiology

Vitamin D and Lung Function

Explore how vitamin D supports lung function through immune regulation, epithelial integrity, inflammatory balance, and whole-system respiratory physiology.

Read more →

Original sources

Source

Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes

Vitamin D is widely reported to inhibit innate immune signalling and dendritic cell (DC) maturation as a potential immunoregulatory mechanism.

Publication details

Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Kundu R et al.. Immunology. 2017;150(1):55 to 63. Published online2016. DOI: 10.1111/imm.12669. PMID: 27608289.

Read more →
Source

Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial

Published in Vargas Buonfiglio LG et al.. BMJ Open Respir Res (2017).

Publication details

Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial. Vargas Buonfiglio LG et al.. BMJ Open Respir Res. 2017;4(1):e000211. DOI: 10.1136/bmjresp-2017-000211. PMID: 28883932.

Read more →
Source

Calcitriol May Down-Regulate mRNA Over-Expression of Toll-Like Receptor-2 and -4, LL-37 and Proinflammatory Cytokines in Cultured Human Keratinocytes

Published in Jeong MS, Kim JY, Lee HI, Seo SJ. Ann Dermatol (2014).

Publication details

Calcitriol May Down-Regulate mRNA Over-Expression of Toll-Like Receptor-2 and -4, LL-37 and Proinflammatory Cytokines in Cultured Human Keratinocytes. Jeong MS, Kim JY, Lee HI, Seo SJ. Ann Dermatol.2014;26(3):296 to 302. DOI: 10.5021/ad.2014.26.3.296. PMID: 24966627.

Read more →